The HeartMate II and HeartMate 3 are manufactured by Thoratec Corp., a subsidiary of Abbott Laboratories. About 14,000 of the ...
Abbott Laboratories’ Thoratec Corp. is recalling 13,883 HeartMate II and HeartMate 3 Left Ventricular Assist Systems according to the Class I recall, which the FDA says is the most serious type.
Abbott announced in January 2024 that it would stop producing its other FDA-approved LVAD offering, the HeartMate II, by 2026. “Having only one device on the market for any condition is not ...
The DeBakey LVAD is a small rotary pump with similar characteristics to HeartMate II. Worldwide clinical experience has shown that this device is suitable for both BTT and DT therapy. The success ...
Under the Agreement, Abbott will share insights from recent HeartMate 3â„¢ trials and will support Cadrenal with: trial design, site identification, trial awareness, and HeartMate 3â„¢ expertise.
Strengthens the Potential for Improved Patient Outcomes through Improvements in the Quality of Anticoagulation, Enhancing Hemocompatibility in HeartMate 3â„¢ LVAD patients Cadrenal Therapeutics ...